Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,776.00
Bid: 2,774.00
Ask: 2,778.00
Change: -28.00 (-1.00%)
Spread: 4.00 (0.144%)
Open: 2,794.00
High: 2,812.00
Low: 2,748.00
Prev. Close: 2,804.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing of Issue of Notes

20 Feb 2024 16:01

RNS Number : 8158D
Coca-Cola HBC AG
20 February 2024

FOR IMMEDIATE RELEASE

Coca-Cola HBC Finance B.V.

(a private limited liability company incorporated in the Netherlands)

Guaranteed by:

Coca-Cola HBC AG

(a company incorporated with limited liability in Switzerland)

Pricing of Issue of Notes

Zug, Switzerland and Amsterdam, The Netherlands - 20 February 2024 - Further to the announcement earlier today, Coca-Cola HBC Finance B.V. (the "Issuer") and Coca-Cola HBC AG ("Coca-Cola HBC") announce the pricing of a ?600 million aggregate principal amount of 3.375% Notes due 2028, to be issued by the Issuer under its ?5,000,000,000 Euro Medium Term Note Programme.

The Notes will be guaranteed by Coca-Cola HBC.

This announcement must be read in conjunction with the Base Prospectus dated 19 December 2023, as supplemented on 15 February 2024 (the "Base Prospectus"), which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

Application will be made for the Notes to be admitted to the Official List of the Financial Conduct Authority and to trading on the Regulated Market of the London Stock Exchange plc. Settlement and the issue of the Notes are expected to occur on 27 February 2024.

Disclaimer

Neither this announcement nor the Base Prospectus constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act.

Please note that the information contained in this announcement and/or the Base Prospectus referred to above may be addressed to and/or targeted at persons who are residents of particular countries (specified in this announcement and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in this announcement and/or the Base Prospectus is not addressed. Prior to relying on the information contained in this announcement and/or the Base Prospectus you must ascertain from this announcement and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

Enquiries

Coca?Cola HBC Group

Investors and Analysts:

John Dawson

Investor Relations Director (Interim)

Tel: +44 7552 619509

john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Virginia Phillips

Investor Relations Manager

Tel: +44 7864 686582

virginia.phillips@cchellenic.com

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

Claire Evans

Group Senior Communications Manager

Tel: +44 7597 562 978

claire.evans@cchellenic.com

ABOUT COCA-COLA HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IODURVVRSWUUUAR
Date   Source Headline
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:42 amRNSAthens Exchange trading date of ordinary shares
1st Jun 20177:54 amRNSIssue of Equity and Total Voting Rights
19th May 201712:24 pmRNSDirector/PDMR Shareholding
16th May 20177:11 amRNSNotice of AGM
15th May 20177:23 amRNSchange to the Board and confirms dividend dates
11th May 20177:00 amRNSYEAR STARTS WELL WITH GOOD REVENUE GROWTH
2nd May 20179:07 amRNSIssue of Equity and Total Voting Rights
2nd May 20178:48 amRNSBlock listing Interim Review
28th Apr 20174:53 pmRNSCoca-Cola HBC Finance B.V. - Annual Report 2016
19th Apr 20174:24 pmRNSDirector/PDMR Shareholding
10th Apr 20173:07 pmRNSNotice of Results
3rd Apr 20178:14 amRNSIssue of Equity and Total Voting Rights
21st Mar 20171:09 pmRNSDirector/PDMR Shareholding
21st Mar 20179:21 amRNSDirector/PDMR Shareholding
17th Mar 20179:15 amRNS2016 Integrated Annual Report
1st Mar 20177:36 amRNSIssue of Equity and Total Voting Rights
20th Feb 20172:37 pmRNSDirector/PDMR Shareholding
16th Feb 20177:00 amRNSCONTINUED GOOD PROGRESS IN MARGIN RECOVERY
1st Feb 20179:55 amRNSIssue of Equity and Total Voting Rights
23rd Jan 20172:14 pmRNSNotice of Results
23rd Jan 20179:12 amRNSDirector/PDMR Shareholding
9th Jan 20179:57 amRNSAthens Exchange trading date of ordinary shares
3rd Jan 20179:28 amRNSIssue of Equity and Total Voting Rights
20th Dec 20162:39 pmRNSDirector/PDMR Shareholding
18th Nov 20161:48 pmRNSDirector/PDMR Shareholding
3rd Nov 20167:00 amRNSSOLID QUARTER CONFIRMS FULL-YEAR EXPECTATIONS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.